A Phase 3 Open-label Study to Evaluate the Safety of MEDI3250 in Healthy Japanese Children Age 2 Years Through 6 Years
Status:
Completed
Trial end date:
2015-02-01
Target enrollment:
Participant gender:
Summary
This open-label, single arm, multicenter study will enroll approximately 100 subjects. The
study is designed to gather the safety and tolerability data in Japanese children 2 to 6
years of age that would support approval of MEDI3250 in Japan.